Publications
Explore 188 academic publications
Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China
Abstract Background Coronavirus disease 2019 (COVID‐19) caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection has been widely spread. We aim to invest...
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study
Abstract Objective To delineate the clinical characteristics of patients with coronavirus disease 2019 (covid-19) who died. Design Retrospective case series. Setting Tongji Hosp...
Federated Learning: Challenges, Methods, and Future Directions
Federated learning involves training statistical models over remote devices or siloed data centers, such as mobile phones or hospitals, while keeping data localized. Training in...
How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules?
In this study, we present conformational energies for a molecular mechanical model (Parm99) developed for organic and biological molecules using the restrained electrostatic pot...
Carbon capture and storage (CCS): the way forward
Carbon capture and storage (CCS) is vital to climate change mitigation, and has application across the economy, in addition to facilitating atmospheric carbon dioxide removal re...
Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
In this international study of CAR T-cell therapy in relapsed or refractory diffuse large B-cell lymphoma in adults, high rates of durable responses were produced with the use o...
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
The guideline panel provided recommendations related to the diagnosis of IPF.
Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis
Background The coronavirus disease 2019 (COVID-19) outbreak is evolving rapidly worldwide. Objective To evaluate the risk of serious adverse outcomes in patients with COVID-19 b...
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
The addition of atezolizumab to bevacizumab plus chemotherapy significantly improved progression-free survival and overall survival among patients with metastatic nonsquamous NS...